Rankings
▼
Calendar
VTRS Q2 2016 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena
VTRS
Viatris Inc.
$16B
Q2 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$2.6B
Gross Profit
$1.2B
45.8% margin
Operating Income
$411M
16.0% margin
Net Income
$168M
6.6% margin
EPS (Diluted)
$0.33
QoQ Revenue Growth
+16.9%
Cash Flow
Operating Cash Flow
$417M
Free Cash Flow
$347M
Stock-Based Comp.
$25M
Balance Sheet
Total Assets
$28.8B
Total Liabilities
$18.5B
Stockholders' Equity
$10.3B
Cash & Equivalents
$6.4B
← FY 2016
All Quarters
Q3 2016 →